Funfact! Common Vampire Bats are being used to make Blood-Thinners and Painkillers with less side effects than most name-brand drugs! https://realitypathing.com/benefits-of-studying-vampire-bats-for-medical-research/
What even is that site, this article on vampire bats stands out like a sore thumb amid the parenting advice and the pseudoscience...though the information the article does provide is correct, it is also devoid of real information and is just a vague overview of what research is being done with vampire bats (or the writing is so "fluffy" I'm zoning out). It also feels like a rewrite of an old Nature article I came across while fact checking (not linked here because I had issues with a paragraph in it that made it sound like Ebola was present in a species of bat that it most certainly wasn't, English is such a wonderful language).
Ahem. Sorry, let me get back on topic.
^Draculin is one of the components in common vampire bat saliva that keeps blood liquid so it can lap it up.
^Desmoteplase is a drug developed by Lundbeck that's based on Draculin. It did not perform very well in tests, and in 2014, Lundbeck announced that they were discontinuing development of this drug.
Intravenous desmoteplase administered 3 to 9 hours after acute ischemic stroke in patients selected with perfusion/diffusion mismatch is ass
^The results from the clinical trials of Desmoteplase, published in 2005? Not clear on exact dates.
Desmolaris, a major anticoagulant from vampire bat saliva, has been identified as a novel FXIa inhibitor. Desmolaris inhibits arterial throm
^As for the pain killer, this anticoagulant present in vampire bat saliva interferes with blood clots in arteries (arterial thrombosis) and inhibits inflammation. Study published in 2013, but I was not able to find any indication that any drug company has had any luck developing it into a drug as yet (I could be wrong on this, I am tired).
The social lives of vampire bats is also the focus of research, I recommend checking out the Carter Lab for more information:
I’m Gerry Carter, an Associate Professor in the Department of Ecology and Evolutionary Biology at Princeton University. My work mainly focus
